Ensysce Biosciences (ENSC) Long-Term Investments (2017 - 2021)
Ensysce Biosciences' Long-Term Investments was $12.69 million in Q1 2021, down 79.3% from $61.33 million a year earlier but up 0.5% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Long-Term Investments (2017 - 2021) Analysis & Trends
At the end of FY2020, Long-Term Investments at Ensysce Biosciences came in at $12.63 million, down 93.5% from FY2019.
- Long-Term Investments shows a three-year compound annual growth rate of -60.2% (FY2017 to FY2020).
- In earlier years, Long-Term Investments was $195.31 million in FY2019 (-3.7%), $202.92 million in FY2018 (+1.4%) and $200.12 million in FY2017.
- Quarterly Long-Term Investments has moved between $12.63 million (Q4 2020) and $205.83 million (Q3 2019) over five years.
- Compared with a year earlier, Long-Term Investments has declined for six straight quarters, with an average decline of 53.8% over the last eight quarters.
- The best year-over-year quarter for Long-Term Investments over five years was Q3 2019 (growth of 1.8%); the worst was Q3 2020 (a decline of 93.6%).
- Per Business Quant data, ENSC's Long-Term Investments in the three quarters before Q1 2021 was $12.63 million (Q4 2020), $13.19 million (Q3 2020) and $13.23 million (Q2 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | - |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Ensysce Biosciences | 1.30 Mn | -10.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 12.69 Mn |
| Dec 31, 2020 | 12.63 Mn |
| Sep 30, 2020 | 13.19 Mn |
| Jun 30, 2020 | 13.23 Mn |
| Mar 31, 2020 | 61.33 Mn |
| Dec 31, 2019 | 195.31 Mn |
| Sep 30, 2019 | 205.83 Mn |
| Jun 30, 2019 | 204.89 Mn |
| Mar 31, 2019 | 203.94 Mn |
| Dec 31, 2018 | 202.92 Mn |
| Sep 30, 2018 | 202.15 Mn |
| Jun 30, 2018 | 201.33 Mn |
| Mar 31, 2018 | 200.75 Mn |
| Dec 31, 2017 | 200.12 Mn |
API Access
Ensysce Biosciences Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();